Another interesting company to diligence is Dyne Therapeutics (DYN) . Their shares were hit pretty hard this week, apparently because they changed primary outcomes for their upcoming DMD readout. Did the market over-react to that, and in the wrong direction? That is something to dig deeper into.

$XBI $93.75 | +3.31% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...

$XBI $93.75 | +3.31% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...

(Posted 10:30am CST) $XBI $92.44 | +1.86% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

(Posted 10:30am CST) $XBI $92.44 | +1.86% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

(Posted 9:55am CST) $XBI $79.73 | -1.19% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

(Posted 9:55am CST) $XBI $79.73 | -1.19% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

$XBI $80.99 | +5.81% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #LXRX +41.8%...

$XBI $80.99 | +5.81% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #LXRX +41.8%...

The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...